HLA-G levels in serum and plasma

Tissue Antigens

Volumn 69, Issue SUPPL. 1, 2007, Pages 140-142

  Rudstein Svetlicky, N ^a   Loewenthal, R ^a   Horejsi, V ^b   Gazit, E ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

Gender; HLA G levels; HLA G plasma; HLA G serum

Indexed keywords

HLA G ANTIGEN;

BLOOD GROUP; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; SERUM; SEX DIFFERENCE;

ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MALE; PLASMA; SERUM; SEX DISTRIBUTION;

EID: 34247235244     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.763_4.x     Document Type: Conference Paper

References (17)

1. Warner CM, Comiskey M, Clisham PR, Brenner CA. Soluble HLA-G (sHLA-G) a predictor of IVF outcome? J Assist Reprod Genet 2004: 21: 315-6.
2. Noci I, Fuzzi B, Rizzo R et al. Embryonic soluble HLA-G as a marker of developmental potential in embryos. Hum Reprod 2005: 20: 138-46. Epub 2004 Oct 21.
3. Creput C, Durrbach A, Charpentier B, Carosella ED, Rouas-Freiss N. [HLA-G: immunoregulatory molecule involved in allograft acceptance]. Nephrologie 2003: 24: 451-6.
4. Amiot L, Le Friec G, Sebti Y et al. HLA-G and lymphoproliferative disorders. Semin Cancer Biol 2003: 13: 379-85.
5. Rebmann V, Regel J, Stolke D, Grosse-Wilde H. Secretion of sHLA-G molecules in malignancies. Semin Cancer Biol 2003: 13: 371-7.
6. Hunt JS, Pace JL, Morales PJ, Ober C. Immunogenicity of the soluble isoforms of HLA-G. Mol Hum Reprod 2003: 9:729-35.
7. Le Bouteiller P, Pizzato N, Barakonyi A, Solier C. HLA-G, pre-eclampsia, immunity and vascular events. J Reprod Immunol 2003: 59: 219-34.
8. Wiendl H, Mitsdoerffer M, Hofmeister V et al. The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy. Brain 2003: 126: 176-85.
9. Rouas-Freiss N, Paul P, Dausset J, Carosella ED. HLA-G promotes immune tolerance. J Biol Regul Homeost Agents 2000: 14: 93-8.
10. Singer G, Rebmann V, Chen YC et al. HLA-G is a potential tumor marker in malignant ascites. Clin Cancer Res 2003: 9: 4460-4.
11. Sebti Y, Le Friec G, Pangault C et al. Soluble HLA-G molecules are increased in lymphoproliferative disorders. Hum Immunol 2003: 64: 1093-101.
12. Rouas-Freiss N, Moreau P, Menier C, Carosella ED. HLA-G in cancer: a way to turn off the immune system. Semin Cancer Biol 2003: 13: 325-36.
13. Rebmann V, Pfeiffer K, Passler M et al. Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 1999: 53: 14-22.
14. Hviid TV, Rizzo R, Christiansen OB, Melchiorri L, Lindhard A, Baricordi OR. HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics 2004: 56: 135-41. Epub 2004 May 7.
15. Yie SM, Li LH, Li YM, Librach CL. HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. Am J Obstet Gynecol 2004: 191: 525-9.
16. Hackmon R, Hallak M, Krup M et al. HLA-G antigen and parturition: maternal serum, fetal serum and amniotic fluid levels during pregnancy. Fetal Diagn Ther 2004: 19: 404-9.
17. Menier C, Saez B, Horejsi V et al. Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules. Hum Immunol 2003: 64: 315-26.